These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 22886526)

  • 1. Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.
    Vangipuram SD; Buck SA; Lyman WD
    Tumour Biol; 2012 Dec; 33(6):2173-83. PubMed ID: 22886526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia.
    Alakhova DY; Zhao Y; Li S; Kabanov AV
    PLoS One; 2013; 8(8):e72238. PubMed ID: 23977261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polarized cell migration induces cancer type-specific CD133/integrin/Src/Akt/GSK3β/β-catenin signaling required for maintenance of cancer stem cell properties.
    Su YJ; Lin WH; Chang YW; Wei KC; Liang CL; Chen SC; Lee JL
    Oncotarget; 2015 Nov; 6(35):38029-45. PubMed ID: 26515729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA-binding motif protein 5 negatively regulates the activity of Wnt/β-catenin signaling in cigarette smoke-induced alveolar epithelial injury.
    Hao YQ; Su ZZ; Lv XJ; Li P; Gao P; Wang C; Bai Y; Zhang J
    Oncol Rep; 2015 May; 33(5):2438-44. PubMed ID: 25738917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway.
    Flahaut M; Meier R; Coulon A; Nardou KA; Niggli FK; Martinet D; Beckmann JS; Joseph JM; Mühlethaler-Mottet A; Gross N
    Oncogene; 2009 Jun; 28(23):2245-56. PubMed ID: 19421142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5-Fluorouracil upregulates the activity of Wnt signaling pathway in CD133-positive colon cancer stem-like cells.
    Deng YH; Pu XX; Huang MJ; Xiao J; Zhou JM; Lin TY; Lin EH
    Chin J Cancer; 2010 Sep; 29(9):810-5. PubMed ID: 20800023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway.
    Zhou W; Li Y; Gou S; Xiong J; Wu H; Wang C; Yan H; Liu T
    Oncotarget; 2015 Nov; 6(35):37557-69. PubMed ID: 26485754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt signalling is a bi-directional vulnerability of cancer cells.
    Duffy DJ; Krstic A; Schwarzl T; Halasz M; Iljin K; Fey D; Haley B; Whilde J; Haapa-Paananen S; Fey V; Fischer M; Westermann F; Henrich KO; Bannert S; Higgins DG; Kolch W
    Oncotarget; 2016 Sep; 7(37):60310-60331. PubMed ID: 27531891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents.
    Vangipuram SD; Wang ZJ; Lyman WD
    Pediatr Blood Cancer; 2010 Mar; 54(3):361-8. PubMed ID: 19927294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
    Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
    Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of Wnt/β-catenin signaling in driving epithelial ovarian cancer platinum resistance.
    Nagaraj AB; Joseph P; Kovalenko O; Singh S; Armstrong A; Redline R; Resnick K; Zanotti K; Waggoner S; DiFeo A
    Oncotarget; 2015 Sep; 6(27):23720-34. PubMed ID: 26125441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin.
    Quan MF; Xiao LH; Liu ZH; Guo H; Ren KQ; Liu F; Cao JG; Deng XY
    World J Gastroenterol; 2013; 19(43):7680-95. PubMed ID: 24431896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic chemotherapeutic stress promotes evolution of stemness and WNT/beta-catenin signaling in colorectal cancer cells: implications for clinical use of WNT-signaling inhibitors.
    Ayadi M; Bouygues A; Ouaret D; Ferrand N; Chouaib S; Thiery JP; Muchardt C; Sabbah M; Larsen AK
    Oncotarget; 2015 Jul; 6(21):18518-33. PubMed ID: 26041882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of WNT signaling reduces differentiation and induces sensitivity to doxorubicin in human malignant neuroblastoma SH-SY5Y cells.
    Suebsoonthron J; Jaroonwitchawan T; Yamabhai M; Noisa P
    Anticancer Drugs; 2017 Jun; 28(5):469-479. PubMed ID: 28240680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of CREB binding protein-beta-catenin signaling down regulates CD133 expression and activates PP2A-PTEN signaling in tumor initiating liver cancer cells.
    Tang Y; Berlind J; Mavila N
    Cell Commun Signal; 2018 Mar; 16(1):9. PubMed ID: 29530069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway.
    Sartelet H; Imbriglio T; Nyalendo C; Haddad E; Annabi B; Duval M; Fetni R; Victor K; Alexendrov L; Sinnett D; Fabre M; Vassal G
    Histopathology; 2012 Jun; 60(7):1144-55. PubMed ID: 22394107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient mTOR inhibition facilitates continuous growth of liver tumors by modulating the maintenance of CD133+ cell populations.
    Yang Z; Zhang L; Ma A; Liu L; Li J; Gu J; Liu Y
    PLoS One; 2011; 6(12):e28405. PubMed ID: 22145042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rab11a sustains GSK3β/Wnt/β-catenin signaling to enhance cancer progression in pancreatic cancer.
    Yu L; Li X; Li H; Chen H; Liu H
    Tumour Biol; 2016 Oct; 37(10):13821-13829. PubMed ID: 27481517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of CD133 promotes drug resistance in C6 glioma cells.
    Angelastro JM; Lamé MW
    Mol Cancer Res; 2010 Aug; 8(8):1105-15. PubMed ID: 20663862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer.
    Arend RC; Londoño-Joshi AI; Samant RS; Li Y; Conner M; Hidalgo B; Alvarez RD; Landen CN; Straughn JM; Buchsbaum DJ
    Gynecol Oncol; 2014 Jul; 134(1):112-20. PubMed ID: 24736023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.